Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer. | Cancers (Basel) | 2022 | 36077820 | PubTator, text mining | PubMed |
| PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA. | Int J Mol Sci | 2022 | 36077458 | PubTator, text mining | PubMed |
| Critical Players and Therapeutic Targets in Chronic Itch. | Int J Mol Sci | 2022 | 36077340 | PubTator, text mining | PubMed |
| A genomic deletion encompassing CRYBB2-CRYBB2P1 is responsible for autosomal recessive congenital cataracts. | Hum Genome Var | 2022 | 36075891 | PubTator, text mining | PubMed |
| The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer. | Cancer Imaging | 2022 | 36057766 | PubTator, text mining | PubMed |
| Cell type-specific calcium imaging of central sensitization in mouse dorsal horn. | Nat Commun | 2022 | 36057681 | PubTator, text mining | PubMed |
| Recent Progress in Second Near-Infrared (NIR-II) Fluorescence Imaging in Cancer. | Biomolecules | 2022 | 36008937 | PubTator, text mining | PubMed |
| pH-responsive graphene oxide loaded with targeted peptide and anticancer drug for OSCC therapy. | Front Oncol | 2022 | 35992794 | PubTator, text mining | PubMed |
| Peptide therapeutics in the management of metastatic cancers. | RSC Adv | 2022 | 35975072 | PubTator, text mining | PubMed |
| Australian aquatic bio-optical dataset with applications for satellite calibration, algorithm development and validation. | Data Brief | 2022 | 35966948 | PubTator, text mining | PubMed |
| Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity. | Eur J Nucl Med Mol Imaging | 2022 | 35951084 | PubTator, text mining | PubMed |
| Exosomes rewire the cartilage microenvironment in osteoarthritis: from intercellular communication to therapeutic strategies. | Int J Oral Sci | 2022 | 35927232 | PubTator, text mining | PubMed |
| Exosome-based strategy for degenerative disease in orthopedics: Recent progress and perspectives. | J Orthop Translat | 2022 | 35891923 | PubTator, text mining | PubMed |
| Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches. | Polymers (Basel) | 2022 | 35890738 | PubTator, text mining | PubMed |
| Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects. | Pharmaceuticals (Basel) | 2022 | 35890193 | PubTator, text mining | PubMed |
| 64Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial. | Pharmaceuticals (Basel) | 2022 | 35890071 | PubTator, text mining | PubMed |
| Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design. | Front Chem | 2022 | 35844642 | PubTator, text mining | PubMed |
| Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancer. | Int J Pharm | 2022 | 35820513 | PubTator, text mining | PubMed |
| Analgesic effect of gastrin-releasing peptide in the dorsal horn. | Mol Pain | 2022 | 35815426 | PubTator, text mining | PubMed |
| Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides. | J Pharm Anal | 2022 | 35811617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=18